Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure
(WorldNews Germany)

Media Release Planegg/Munich, Germany, November 20, 2019 Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; Nasdaq: MOR) today announced that Dr. Markus Enzelberger, the company`s Chief Scientific Officer (CSO), has decided to step down as CSO and member of the company`s Management Board to explore new opportunities. Dr. Enzelberger will leave MorphoSys on February 29, 2020. Following Dr. Enzelberger`s departure, the MorphoSys research organization will be integrated into the Clinical Development segment under the lead of Dr. Malte Peters, Chief Development Officer. Dr. Enzelberger joined...